BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16534510)

  • 1. Prostate activity and prostate cancer in spinal cord injury.
    Shim HB; Jung TY; Lee JK; Ku JH
    Prostate Cancer Prostatic Dis; 2006; 9(2):115-20. PubMed ID: 16534510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries.
    Bartoletti R; Gavazzi A; Cai T; Mondaini N; Morelli A; Del Popolo G; Geppetti P
    Eur Urol; 2009 Jul; 56(1):142-8. PubMed ID: 18280636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients.
    Scott PA; Perkash I; Mode D; Wolfe VA; Terris MK
    Urology; 2004 Mar; 63(3):509-12. PubMed ID: 15028447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of spinal cord injury on the status of messenger ribonucleic acid for TRPM 2 and androgen receptor in the prostate of the rat.
    Huang HF; Li MT; Linsenmeyer TA; Ottenweller JE; Pogach LM; Irwin RJ
    J Androl; 1997; 18(3):250-6. PubMed ID: 9203052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of prostate cancer in patients with chronic spinal cord injury.
    Patel N; Ngo K; Hastings J; Ketchum N; Sepahpanah F
    PM R; 2011 Jul; 3(7):633-6. PubMed ID: 21777862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of prostate size, PSA and endocrine profiles in patients with spinal cord injuries.
    Benaim EA; Montoya JD; Saboorian MH; Litwiller S; Roehrborn CG
    Prostate Cancer Prostatic Dis; 1998 Sep; 1(5):250-255. PubMed ID: 12496884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
    Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
    Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen levels as a predictor of lethal prostate cancer.
    Fall K; Garmo H; Andrén O; Bill-Axelson A; Adolfsson J; Adami HO; Johansson JE; Holmberg L;
    J Natl Cancer Inst; 2007 Apr; 99(7):526-32. PubMed ID: 17405997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment for prostate cancer in patients with prior spinal cord injury.
    Gammon SR; Berni KC; Virgo KS; Johnson FE
    Ann Surg Oncol; 2005 Aug; 12(8):674-8. PubMed ID: 15968495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia in the acute stage after traumatic cervical spinal cord injury: clinical and neuroanatomic evidence for autonomic dysfunction.
    Furlan JC; Fehlings MG
    Spine (Phila Pa 1976); 2009 Mar; 34(5):501-11. PubMed ID: 19212273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Men with spinal cord injury have a smaller prostate than men without.
    Hvarness H; Jakobsen H; Biering-Sørensen F
    Scand J Urol Nephrol; 2007; 41(2):120-3. PubMed ID: 17454950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA levels in men with spinal cord injury and under intermittent catheterization.
    Torricelli FC; Lucon M; Vicentini F; Gomes CM; Srougi M; Bruschini H
    Neurourol Urodyn; 2011 Nov; 30(8):1522-4. PubMed ID: 21661042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
    BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
    Nanda A; Chen MH; Renshaw AA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive establishment of airway control is critical for optimal outcome in lower cervical spinal cord injury.
    Hassid VJ; Schinco MA; Tepas JJ; Griffen MM; Murphy TL; Frykberg ER; Kerwin AJ
    J Trauma; 2008 Dec; 65(6):1328-32. PubMed ID: 19077622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.